SHINE Medical Technologies plans to locate its European medical isotope production facility in the Netherlands after a yearlong search and a review of more than 50 proposals from sites across Europe. The company announced on May 20 that construction at the site should begin in 2023 with commercial production starting in late 2025.

Within the European Union, recognizing nuclear energy as green, sustainable, and worthy of investment depends on nuclear being added to the EU taxonomy of “sustainable investments that have been found to ‘do no significant harm’ to human health and to the environment.” The EU will issue a final taxonomy this year, and a decision to include nuclear power—which was excluded from a draft released in late 2020—could raise prospects for public and private nuclear investments both inside and outside the EU.

The decision rests with the European Commission (EC), which will take into consideration expert opinions, including those in a scientific report of the EC’s Joint Research Centre (JRC) that was requested last summer. The JRC's 387-page report, Technical assessment of nuclear energy with respect to the ‘do no significant harm’ criteria of Regulation (EU) 2020/852 (‘Taxonomy Regulation’), was leaked to the media and made available online on March 26. The report supports adding nuclear to the taxonomy.